• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Magnesium orotate--experimental and clinical evidence.

作者信息

Classen H G

机构信息

Pharmacology and Toxicology of Nutrition University of Hohenheim Stuttgart, Deuschland.

出版信息

Rom J Intern Med. 2004;42(3):491-501.

PMID:16366126
Abstract

Magnesium orotate dihydrate (MO) has the sum formula C10H6MgN4O8 x 2H2O and a MG of 370.52. The salt is poorly soluble in water and hence does not bind gastric acid nor does it exhibit noteworthy laxative effects upon oral administration in contrast to easily dissociable Mg salts. As a source of magnesium (Mg), MO is indicated for the oral treatment of extracellular Mg deficiency. Orotic acid (OA), the second active ingredient of MO, is a key intermediate in the biosynthetic pathway of pyrimidines and is shown to improve the energy status of injured myocardium by stimulating, a.o., the synthesis of glycogen and ATP. Myocardial energy-rich phosphate levels are decreased during hypoxic conditions; subsequently, intracellular Mg is depleted and lost via the urine. Since binding sites for Mg (ATP) are provided by OA it can be classified as "Mg-fixing agent". Accordingly MO is also indicated for the treatment of Mg depletion as convincingly shown in animal experiments and also in coronary heart patients undergoing e.g. aortocoronary bypass surgery.

摘要

相似文献

1
Magnesium orotate--experimental and clinical evidence.
Rom J Intern Med. 2004;42(3):491-501.
2
[Effect of magnesium orotate and orotic acid on induced blood pressure elevation and cardiopathogenic changes of the myocardium in animal experiments].
Dtsch Med J. 1970 Nov 20;21(22):1405-12.
3
Metabolic supplementation with orotic acid and magnesium orotate.用乳清酸和乳清酸镁进行代谢补充。
Cardiovasc Drugs Ther. 1998 Sep;12 Suppl 2:147-52. doi: 10.1023/a:1007732131887.
4
Magnesium orotate in severe congestive heart failure (MACH).
Int J Cardiol. 2009 Jan 9;131(2):293-5. doi: 10.1016/j.ijcard.2007.11.022. Epub 2008 Feb 20.
5
Magnesium orotate in myocardial and neuronal protection.
Rom J Intern Med. 1999 Jan-Mar;37(1):91-7.
6
[Magnesium metabolism from the cardioangiologic viewpoint. I. Findings on magnesium metabolism in heart diseases].
Z Gesamte Inn Med. 1972 Jan 15;27(2):45-9.
7
[Causes of the multilayered effect of magnesium orotate in degenerative heart and vascular diseases (vascular sclerosis)].
Dtsch Med J. 1968 Dec 20;19(24):868-71.
8
Morphological aspects of the effects of orotic acid and magnesium orotate on hypercholesterolaemia in rabbits.
Arzneimittelforschung. 1995 Aug;45(8):836-42.
9
[Clinical experiments with a new myocardiotrophic agent].
Clin Ter. 1970 Sep 15;54(5):441-53.
10
[Meta-analysis of clinical trials of cardiovascular effects of magnesium orotate].[乳清酸镁对心血管影响的临床试验的荟萃分析]
Ter Arkh. 2015;87(6):88-97. doi: 10.17116/terarkh201587688-97.

引用本文的文献

1
Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer's Disease.次生植物代谢物和微量元素的联合作用改善早发性阿尔茨海默病细胞模型中的线粒体功能。
Int J Mol Sci. 2023 Jun 12;24(12):10029. doi: 10.3390/ijms241210029.
2
Magnesium Deficiency and Cardiometabolic Disease.镁缺乏与心脏代谢疾病。
Nutrients. 2023 May 17;15(10):2355. doi: 10.3390/nu15102355.
3
Effects of Combining Biofactors on Bioenergetic Parameters, Aβ Levels and Survival in Alzheimer Model Organisms.
生物因素联合作用对阿尔茨海默病模型生物能量学参数、Aβ 水平和存活的影响。
Int J Mol Sci. 2022 Aug 4;23(15):8670. doi: 10.3390/ijms23158670.
4
Lithium orotate: A superior option for lithium therapy?L- 羟赖氨酸:锂治疗的更佳选择?
Brain Behav. 2021 Aug;11(8):e2262. doi: 10.1002/brb3.2262. Epub 2021 Jul 1.